TrialJournal of translational medicine2010

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.

Osama E Rahma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.